The company specializes in gastroenterology, hepatology, cancer and supportive care. Its annual sales are in excess of $400 million.

In 2012, the group established a complementary business, Norgine Ventures, supporting innovative healthcare companies through the provision of debt-like financing in Europe and the USA.